According to a recent LinkedIn post from Veesion, the company’s team engaged with more than 300 pharmacists during the Pharmagora 2026 trade show at stand M56. The post suggests that many pharmacy professionals report significant but poorly quantified theft-related losses that are difficult to identify in real time and often underestimated.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post highlights recurring theft behaviors in retail pharmacy settings and positions Veesion’s AI-based solution as a tool aimed at making such losses more visible and manageable. For investors, this emphasis on a clearly articulated pain point and strong engagement with pharmacists may indicate sustained demand potential in the pharmacy and broader retail verticals.
The post also references a client intervention during a conference session, which is presented as evidence of real-world relevance and validation from existing users. This type of customer-driven advocacy could support Veesion’s commercial traction, helping the company deepen its footprint in the pharmacy segment and potentially improve pricing power and retention over time.
By framing its product as simple, concrete, and useful in daily operations, Veesion appears to be targeting operational efficiency and loss-prevention budgets rather than discretionary spending. If the company can convert high interest at events like Pharmagora into contracted deployments, it could expand recurring revenue and strengthen its position in the AI-powered retail loss-prevention market.
The call to continue discussions with stakeholders who could not attend the event suggests an ongoing lead-generation effort beyond the trade show. For investors, this points to a sales pipeline strategy that leverages industry events as a starting point for deeper commercial conversations with pharmacy and retail prospects.

